货号: CL-0568
Price: ¥1600 ¥1600
生长培养基: RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]+0.1 mM NEAA[PB180424]+1 mM Sodium Pyruvate[PB180422]+2 mM L-glutamine[PB180420]
产品信息
产品名称 | Renca [RenCa](小鼠肾癌细胞) |
别称 | Renca; RENCA; Renal Carcinoma |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]+0.1 mM NEAA[PB180424]+1 mM Sodium Pyruvate[PB180422]+2 mM L-glutamine[PB180420] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:3-1:6 |
推荐换液频率 | 2-3次/周 |
注意事项 |
|
参考资料(来源文献)
年龄(性别) | 6W Male |
组织来源 | 肾脏 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肾癌细胞 |
生物安全等级 | BSL-1 |
STR位点信息
STR鉴定图
-
Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy(2024)
作者:Xiu-Hai Wu, Jia-Qi Wang, Man-Di Wang, Ting Xiao, Yu Wang, Jia-Yuan Niu, Lu Wang, Da-Yong Hou, Bo Fu, Zimo Liu, Hao Wang, Wan-Hai Xu
期刊:BIOMATERIALS
DOI:10.1016/j.biomaterials.2024.122550
影响因子:14.0
-
Biomimetic Nano-regulator that Induces Cuproptosis and Lactate-Depletion Mediated ROS Storm for Metalloimmunotherapy of Clear Cell Renal Cell Carcinoma(2024)
作者:Xiaotong Xu, Huimin Li, Binghua Tong, Weijie Zhang, Xiaofei Wang, Yue Wang, Geng Tian, Zhaowei Xu, Guilong Zhang
期刊:Advanced Healthcare Materials
影响因子:10.0
引用产品: Renca [RenCa] 细胞, RPMI-1640 培养基, MEM非必需氨基酸溶液(NEAA),100×, 丙酮酸钠溶液(100 mM),100×, L-谷氨酰胺溶液(200 mM),100×
-
A platinum(IV)–artesunate complex triggers ferroptosis by boosting cytoplasmic and mitochondrial lipid peroxidation to enhance tumor immunotherapy(2024)
作者:Renming Fan, Aohua Deng, Ruizhuo Lin, Shuo Zhang, Caiyan Cheng, Junyan Zhuang, Yongrui Hai, Minggao Zhao, Le Yang, Gaofei Wei
期刊:MedComm
DOI:10.1002/mco2.570
影响因子:9.9
-
A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression(2024)
作者:Yongrui Hai, Renming Fan, Ting Zhao, Ruizhuo Lin, Junyan Zhuang, Aohua Deng, Shanshui Meng, Zhuang Hou, Gaofei Wei
期刊:PHARMACOLOGICAL RESEARCH
DOI:10.1016/j.phrs.2024.107115
影响因子:9.3
引用产品: B16-F10 细胞, A-375 细胞, 4T1 细胞, Renca [RenCa] 细胞, GL261 细胞, U-87 MG 细胞, SH-SY5Y [SHSY-5Y] 细胞, U251 细胞
-
Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-g-methoxy poly (ethylene glycol)/combretastatin A4/BLZ945 nanoparticles on Renca renal carcinoma(2024)
作者:Chen Jiaqi, Yin Min, Yang Chenguang, Wang Kun, Ma Lili, Yu Haiyang, Huang Yue, Liu Feng, Tang Zhaohui
期刊:Frontiers in Bioengineering and Biotechnology
DOI:10.3389/fbioe.2024.1336692
影响因子:5.7
引用产品: Renca [RenCa] 细胞
-
Improved Immunotherapy Outcomes via Cuproptosis Upregulation of HLA-DRA Expression: Promoting the Aggregation of CD4+ and CD8+T Lymphocytes in Clear Cell Renal Cell Carcinoma(2024)
作者:Bowen Wang, Yiwen Liu, Feng Xiong, Chunyang Wang
期刊:Pharmaceuticals
影响因子:4.3
引用产品: 786-O [786-0] 细胞, OS-RC-2 细胞, A-498 细胞, HK-2 细胞, Renca [RenCa] 细胞
-
RNF26 up-regulates PD-L1 to regulate the cancer immune response in ccRCC(2024)
作者:WEIGANG REN, JING LI, RUIJIANG ZENG, LIANG ZHU
期刊:BIOCELL
DOI:10.32604/biocell.2024.051747
影响因子:0.8
引用产品: Renca [RenCa] 细胞, MEM(ATCC改良) 培养基, A-498 细胞, Renca [RenCa]细胞专用培养基
-
Oxyhaemoglobin saturation NIR-IIb imaging for assessing cancer metabolism and predicting the response to immunotherapy(2023)
作者:Fang Zhiguo, Wang Chenlei, Yang Jingrun, Song Zhizheng, Xie Chunyu, Ji Yu, Wang Zhongliang, Du Xiaohui, Zheng Qiang, Chen Chunying, Hu Zhiyuan, Zhong Yeteng
期刊:Nature Nanotechnology
DOI:10.1038/s41565-023-01501-4
影响因子:38.3
引用产品: 4T1 细胞, EMT6 [EMT-6] 细胞, Renca [RenCa] 细胞, LLC [LL/2; LLC1] 细胞, CT26.WT 细胞, MFC 细胞
-
Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma(2023)
作者:Le Li, Xing Zeng, Zheng Chao, Jing Luo, Wei Guan, Qiang Zhang, Yue Ge, Yanan Wang, Zezhong Xiong, Sheng Ma, Qiang Zhou, Junbiao Zhang, Jihua Tian, David Horne, Bertram Yuh, Zhiquan Hu, Gong-Hong Wei, Baojun Wang, Xu Zhang, Peixiang Lan, Zhihua Wang
期刊:Advanced Science
影响因子:15.1
引用产品: Renca [RenCa] 细胞, B16-F10 细胞
-
Novel Pt(IV) complex OAP2 induces STING activation and pyroptosis via mitochondrial membrane remodeling for synergistic chemo-immunotherapy(2023)
作者:Renming Fan, Ruizhuo Lin, Shuo Zhang, Aohua Deng, Yongrui Hai, Junyan Zhuang, Yang Liu, Maosheng Cheng, Gaofei Wei
期刊:Acta Pharmaceutica Sinica B
DOI:10.1016/j.apsb.2023.11.032
影响因子:14.5
引用产品: 4T1 细胞, B16-F10 细胞, Renca [RenCa] 细胞, PUMC-HUVEC-T1 细胞
-
Q1:Renca[RenCa](小鼠肾癌细胞)是否可以做成瘤实验?
有资料显示可以成瘤,具体参考Explore RenCa Cells | Cytion: Cells for Innovation https://www.cytion.com/RenCa-Cells/400321
-
Q2:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图